Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severity of overactive bladder symptoms and response to dose escalation in a randomized, double-blind trial of solifenacin (SUNRISE)

Published:2013-01-07 Issue:5 Volume:111 Page:804-810
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Cardozo Linda¹,Amarenco Gerard²,Pushkar Dmitry³,Mikulas Jura⁴,Drogendijk Ted⁵,Wright Mark⁶,Compion Gerhard⁶,

Affiliation:

1. King's College Hospital; London; UK

2. Hôpital Tenon; Paris; France

3. Moscow State University of Medicine and Dentistry; Moscow; Russia

4. Faculty Hospital; Zilina; Slovak Republic

5. Astellas Pharma Europe B.V.; Leiderdorp; the Netherlands

6. Astellas Pharma Europe Ltd; Medical Affairs; Chertsey; UK

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11654.x/fullpdf

Reference17 articles.

1. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society;Abrams;Neurourol Urodyn,2002

2. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Int Urogynecol J Pelvic Floor Dysfunct,2010

3. Comorbidities associated with overactive bladder;Brown;Am J Manag Care,2000

4. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

5. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms—A randomized controlled trial;LUTS: Lower Urinary Tract Symptoms;2023-05-16

2. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09

3. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

4. Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta‐analysis;LUTS: Lower Urinary Tract Symptoms;2023-03-02

5. Safety and tolerability of solifenacin in children and adolescents with overactive bladder- a systematic review;Journal of Pediatric Urology;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3